HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohamed R Daha Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

10/2011Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.
5/2010The complement system in systemic autoimmune disease.
10/2007Immune modulation of human dendritic cells by complement.
1/2007The clearance of apoptotic cells by complement.
1/2006Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus.
11/2005Role of complement in innate and autoimmunity.
4/2005Activation of the lectin pathway in murine lupus nephritis.
2/2005Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.
9/2004Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.
6/2002Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohamed R Daha Research Topics

Disease

27Inflammation (Inflammations)
01/2021 - 05/2001
18IGA Glomerulonephritis (IGA Nephropathy)
12/2021 - 02/2003
12Reperfusion Injury
01/2019 - 09/2002
10Infections
01/2018 - 08/2002
10Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2011 - 06/2002
9Macular Degeneration (Age-Related Maculopathy)
12/2020 - 11/2007
9Proteinuria
01/2019 - 06/2006
7Brain Death (Brain Dead)
01/2021 - 04/2011
7Renal Insufficiency (Renal Failure)
01/2019 - 08/2007
7Lupus Nephritis
12/2018 - 02/2005
7Autoimmune Diseases (Autoimmune Disease)
04/2012 - 08/2002
6Ischemia
01/2017 - 11/2005
5Chronic Kidney Failure (Chronic Renal Failure)
01/2019 - 08/2010
5Glomerulonephritis
10/2011 - 10/2005
3Disease Progression
11/2020 - 12/2006
3Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
12/2018 - 09/2009
3Fibrosis (Cirrhosis)
01/2018 - 12/2003
3Necrosis
01/2017 - 07/2002
3Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 08/2007
3Diabetic Nephropathies (Diabetic Nephropathy)
07/2004 - 03/2003
2Chronic Renal Insufficiency
01/2021 - 01/2019
2Anemia
01/2019 - 01/2017
2Hypersensitivity (Allergy)
01/2017 - 01/2014
2Wounds and Injuries (Trauma)
01/2016 - 07/2007
2Atherosclerosis
07/2011 - 06/2006
2Nephritis
09/2010 - 09/2009
2Albuminuria
09/2009 - 09/2004
2Mannose-Binding Protein Deficiency
01/2008 - 09/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2007 - 10/2005
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2001 - 04/2000
1Lung Injury
01/2021
1Hereditary Complement Deficiency Diseases
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Malnutrition (Nutritional Deficiencies)
12/2020
1Pre-Eclampsia (Preeclampsia)
01/2019
1Pregnancy Complications
01/2019
1Acute Kidney Injury (Acute Renal Failure)
12/2018
1Disease Susceptibility (Diathesis)
01/2018
1Atypical Hemolytic Uremic Syndrome
08/2016
1Thrombocytopenia (Thrombopenia)
08/2016
1Thrombotic Microangiopathies
08/2016
1Sepsis (Septicemia)
01/2016
1Delayed Graft Function
06/2015
1Hypoxia (Hypoxemia)
06/2015

Drug/Important Bio-Agent (IBA)

52Complement System Proteins (Complement)IBA
12/2021 - 05/2002
14LectinsIBA
01/2021 - 09/2004
11Immunoglobulin A (IgA)IBA
02/2016 - 02/2003
9Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2016 - 09/2004
7AntibodiesIBA
04/2012 - 08/2002
5Complement Factor H (Factor H)IBA
01/2018 - 11/2007
5AutoantibodiesIBA
10/2011 - 09/2004
4ProperdinIBA
01/2021 - 04/2010
4Biomarkers (Surrogate Marker)IBA
11/2020 - 01/2008
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2008
3Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2019 - 07/2011
3CreatinineIBA
01/2019 - 08/2016
3Immunoglobulin G (IgG)IBA
12/2018 - 09/2009
3Glucose (Dextrose)FDA LinkGeneric
07/2004 - 03/2003
2PTX3 proteinIBA
01/2021 - 02/2003
2ferric carboxymaltoseIBA
01/2019 - 01/2017
2Complement Factor B (Factor B)IBA
01/2019 - 01/2008
2Complement C3 (C3 Complement)IBA
01/2019 - 04/2011
2IronIBA
01/2019 - 01/2017
2chemotactic factor inactivatorIBA
03/2016 - 07/2013
2IgA receptor (protein B)IBA
04/2013 - 02/2003
2Nucleosomes (Nucleosome)IBA
10/2011 - 05/2007
2AntigensIBA
10/2011 - 07/2010
2Immunoglobulins (Immunoglobulin)IBA
02/2011 - 05/2010
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2010 - 04/2000
2Antigen-Antibody Complex (Immune Complex)IBA
05/2010 - 01/2010
2Biological ProductsIBA
01/2010 - 01/2006
2antiglomerular basement membrane antibodyIBA
09/2009 - 09/2004
2Secretory Immunoglobulin A (SIgA)IBA
01/2008 - 11/2007
2CytokinesIBA
06/2005 - 04/2004
2Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2004 - 03/2003
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2003 - 03/2003
2AutoantigensIBA
05/2001 - 04/2000
2Myeloblastin (Proteinase 3)IBA
05/2001 - 04/2000
1E-SelectinIBA
01/2021
1InterleukinsIBA
01/2021
1Essential Amino AcidsIBA
12/2020
1Lipoproteins (Lipoprotein)IBA
12/2020
1Indicators and Reagents (Reagents)IBA
11/2020
1Pharmaceutical PreparationsIBA
01/2019
1Saccharated Ferric Oxide (Venofer)FDA Link
01/2019
1Complement Inactivating AgentsIBA
12/2018
1LigandsIBA
12/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Dextrans (Dextran)FDA Link
01/2017
1Polysaccharides (Glycans)IBA
01/2017
1Complement Receptors (Complement Receptor)IBA
01/2017
1eculizumabFDA Link
08/2016

Therapy/Procedure

8Transplantation
01/2019 - 08/2005
6Therapeutics
10/2021 - 08/2010
5Renal Dialysis (Hemodialysis)
01/2021 - 01/2016
5Kidney Transplantation
01/2017 - 08/2007
4Organ Transplantation
01/2021 - 08/2005
2Catheters
01/2019 - 01/2018
2Liver Transplantation
09/2010 - 08/2005
1Tissue and Organ Harvesting
06/2015